Volume : 32 Issue : 4 Year : 2017
About the Journal
Medeniyet Medical Journal (MMJ) is the open access, scientific international
publication of the Istanbul Medeniyet University School of Medicine that is
published in accordance with independent, double-blind peer review principles.
Journals former name was “Göztepe Týp Dergisi” between 1985 and 2015.
AIMS AND SCOPE
The journal aims to publish scientifically high-quality articles such as research
articles, reviews, invited reviews, case reports, scientific meeting abstracts and
letters to the editor in all aspects of both clinical and experimental scientific kind
of researches in all fields of medical science.
It is published four times per year by Medeniyet Medical Journal Academic
Group both in English and Turkish language in (signify the months)
ABSTRACTING AND INDEXING
The Medeniyet Medical Journal is currently indexed in Index Copernicus,
Scopus, ULAKBIM, EBSCO Academic Search Complete, Pleksus Turk Medline,
Turk Atýf Dizini, and Turkish Medical Database.
MMJ publishes original articles on clinical and experimental research related to
any area of medicine. Editorials, letter to the editor, review articles, case reports
and technical note on clinical observations may also be considered. By
submitting a manuscript to this journal, authors accept that their manuscript may
be screened for plagiarism against previously published works.
Processing and publication are FREE of charge. No fees are requested from the
authors at any point throughout the evaluation and publication process. One of
the main goals of the journal is to provide global researchers with a free
publishing platform. Anyone can use the articles as long as the credit is given to
the author and citation to the original source. It is available to reach the articles
by search engines, websites, blogs and other digital platforms.
POLICY OF SCREENING FOR PLAGIARISM
The manuscripts are scanned by the Publisher’s Office using the iThenticate
program for determination of plagiarism and non-ethical situations.
The corresponding author will receive an e-mail that informs the status of the
manuscript at any step of reviewing and publishing process.
MANUSCRIPT FORMAT AND STYLE
Manuscripts should be written in Turkish or in English. If the manuscript is in
Turkish, it must also include English abstract and Keywords.
Papers should be typed in 12-point typescript and double-spaced throughout the
text including tables and references with wide margins (2.5 cm) on each side of
a standard A4 paper.
The manuscript should include the following: (i) title page, (ii) abstract, (iii)
main text (introduction, materials and methods, results, discussion), (iv)
references, (v) figure legends, (vi) tables, (vii) figures.
The first page should contain: a title of the paper, suggested running headline of
not more than 30 characters (including both letters and spaces) and author’s
name, department, institution, city and, country. Authors that work different
department or center should be indicated by superscript numbers. The title page
should carry the name and address of the author to whom correspondence.
Telephone and fax numbers (as well as an e-mail address if available) should
also be given. The corresponding author will receive an e-mail alert containing a
link to a website. Therefore, a working e-mail address must be provided for the
Abstract word count must be between 150 and 250. The subtitles are not needed.
But, it should be covered;
Give a short information about the studied topics and clear statement of the main
aim of the study and the main hypothesis
Describe the setting of the study.
Abstract in English is necessary for the manuscript written in Turkish.
Give the main results of the study.
State the primary conclusions of the study and their clinical implications.
Suggest areas for further research, if appropriate.
Abbreviations: Abbreviations should be standard. Any nonstandard
abbreviations should be defined in the text when first used.
Tables and legends: Tables and legends should be typed on separate pages at the
end of the manuscript. Any explanation should be defined as a footnote, not in
the legend line.
All illustrations, artworks and figures should be original. It is the authors’
responsibility to obtain necessary permissions for any material with copyright.
Illustrations, figures and graphics should be prepared in tiff format with a
minimum resolution of 300 dpi. They should be clear, sharp, easily readable and
legible. Illustrations must be cited in consecutive numerical order in the text.
The staining method and the magnification rate should be indicated in
microscopic illustrations (e.g. H&E, x400). Submitted photographs, figures and
graphics should be of professional quality. Legends for the figures should be
typed double-spaced on a separate page. They must be concise and represent
summaries of findings. Authors should retain one copy of original artwork.
The authors have to list at least three, but no more than five keywords below the
abstract. Preferably use terms from the ‘Medical Subject Headings’ (http://
www.nlm.nih.gov/mesh/MBrowser.html) list from Index Medicus. If the
manuscript is written in Turkish, it is recommended to select the keywords from
‘Türkiye Bilim Terimleri’ (http://www.bilimterimleri.com).
Financial support, technical and other assistance of importance for the study
may be acknowledged before references.
Number references consecutively in the order in which they are first mentioned
in the text. Identify references in text, tables and captions by Arabic numerals in
[square] brackets. Use the references form adopted by the US National Library
of Medicine. Titles of journals should be abbreviated according to the style used
in Index Medicus. In the list, reference can be made by only published or
accepted articles.Number of references must be truncated by 15, 30 and 40 references for case report, original investigation and review article, respectively.
For journal articles
Altundag O, Gullu I, Altundag K, et al. Induction chemotherapy with cisplatin
and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the
treatment of locoregionally advanced resectable cancers of the larynx and
hypopharynx: results of single-center study of 45 patients. Head
Journal article in press
Cengiz M, Ozyigit G, Yazici G, et al. Salvage Reirradiaton with Stereotactic
Body Radiotherapy for Locally Recurrent Head-and-Neck Tumors. Int J Radiat
Oncol Biol Phys 2010 Jul 31. doi:10.1016/j.ijrobp.2010.04.027
For book references
Chao KSC, Ozyigit G. Intensity Modulated Radiation Therapy for Head&Neck
Cancer. 1st edition. Philadelphia, Lippincott Williams & Wilkins, 2003: 34-36.
Ozyigit G, Beyzadeoglu M, Ebruli C. Genitourinary system cancers. In: Basic
Radiation Oncology. Beyzadeoglu M, Ozyigit G, Ebruli C (eds). 1st edition.
Springer-Verlag Berlin, Heidelberg, 2010: 363-410.
For congress presentations
Appelbaum FR, Gilliland DG, Tallman MS. The biology and treatment of acute
myeloid leukemia. In: 40th Annual Meeting of the American Society of
Hematology Education Book. McArthur JR, Schechter GP, Schrier SL (eds).
December 4-8, 1998, Miami Beach, Florida, 1998: 10-13.
Ayhan A, Yasui W, Yokozaki H, Tahara E. Gastrointestinal karsinomlarda bcl-2
ekspresyonu ve gen degisiklikleri. XII. National Cancer Congress, Antalya, April
23-26, 1997: P307.
Güllü IH. Mide kanserli hastalarda 5-florourasil, adriamisin, mitomisin
kombine kemoterapisinin degerlendirilmesi. Hacettepe University Faculty of Medicine, Oncology Institute, Medical Oncology Department Graduate Thesis,
http://www.cancer.gov/cancertopics/types/bladder (Access date: 12/14/208).
In case of use of a previously published table, figure or illustration, reference of
the material must be cited in reference list.
Accepted Articles should be designed by the authors. Designed Articles are
published in online issue without having been copy-edited. Medeniyet medical
journal (MMJ) cannot be held responsible for errors or consequences arising
from the use of information contained in these articles; nor do the views and
Accepted Articles appear in PDF format.
Submission is considered on the conditions that papers are previously
unpublished, and are not offered simultaneously elsewhere; that authors have
read and approved the content, and all authors have also declared all competing
interests; and that the work complies with the Ethical Approval and has been
conducted under internationally accepted ethical standards. If ethical
misconduct is suspected, the Editorial Board will act in accordance with the
relevant international rules of publication ethics (i.e., COPE guidelines). To
verify the originality of content submitted to MMJ, iThenticate is used to check
submissions against previous publications.
HUMAN AND ANIMAL RIGHTS
The policy of the journal is respectful of the Human and Animal Rights.
If the work involves the use of human or animal subjects, an approval of
research protocols by an ethics committee in accordance with international
agreements (“WMA Declaration of Helsinki - Ethical Principles for Medical
Research Involving Human Subjects, October 2013, Fortaleza, Brazil”, "Guide
for the care and use of laboratory animals, 8th edition, 2011" and/or
“International Guiding Principles for Biomedical Research Involving Animals,
2012”) is required for all research studies. Authors should include a statement in
the manuscript that informed consent was obtained for experimentation with
human subjects. The privacy rights of human subjects must always be observed.
If the submitted manuscript does not include ethics committee approval, it will be reviewed according to COPE's guideline (Guidance for Editors: Research,
Audit and Service Evaluations).
SUBMISSION OF MANUSCRIPTS
All manuscripts should be written in English or Turkish language and prepared
in Microsoft Word format. Language editing should also be appropriate for an
academic journal. Tables, figures and pictures should be embedded in
appropriate part of manuscript. The SI system must be used. To be considered
for publication, the author should also provide suggestions for at least two
reviewers. MMJ will evaluate manuscripts submitted via journal’s online
manuscript submission system (www.medeniyetmedicaljournal.org). Our journal
now uses an online submission and peer review
system in ScopeMed (www.scopemed.org). This can bring a number of
advantages to authors, referees, the editorial office and the publishing process in
general. To submit online a paper to MMJ, you can access ScopeMed Online
Submission System by clicking http://my.ejmanager.com/ms/. In case of any
problem or technical error to access the online submission system, please
contact directly to the Editor by e-mail (firstname.lastname@example.org).
Corresponding author must give signed consent to publication in a covering
letter including the following information.
• A statement that the manuscript has not been published elsewhere, and
that, if accepted in MMJ will not be republished in any other journal in
the same or similar form. Written permission must be obtained from the
copyright holder for reproduction of figures published elsewhere.
• A statement of financial or other relationships that might lead to a conflict
• A statement that the manuscript has been read and approved by all
When manuscript is submitted to MMJ, the author(s) grant(s) to the Publisher
exclusive first publication rights in website and press, and further grant(s) a nonexclusive
license for other uses of the Work for the duration of its copyright in
all languages, throughout the world, in all media. The Publisher shall include a
notice in the Work saying “© [Author’s Name]. Readers of this article may copy
it without the copyright owner’s permission, if the author and publisher are
acknowledged in the copy and copy is used for educational, not-for-profit purposes.”
Prior to acceptance all articles undergo peer-review process and will be accepted
or rejected based on their own merit.
All pages (including references, tables and their captions, figure captions and
[where possible] figures) should be saved in a single electronic file.